Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)
South Korea · Delayed Price · Currency is KRW 973.00
0.00 (0.00%)
At close: Nov 12, 2025
KRX:002210 Revenue
In the year 2011, Dong Sung Bio Pharm.Co.,Ltd. had annual revenue of 78.44B KRW with 9.06% growth. Dong Sung Bio Pharm.Co.,Ltd. had revenue of 18.57B in the quarter ending June 30, 2013, a decrease of -0.97%.
Revenue
78.44B
Revenue Growth
+13.99%
P/S Ratio
0.30
Revenue / Employee
270.49M
Employees
290
Market Cap
23.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2011 | 78.44B | 6.52B | 9.06% |
| Dec 31, 2010 | 71.93B | 3.20B | 4.66% |
| Dec 31, 2009 | 68.72B | 6.49B | 10.43% |
| Dec 31, 2008 | 62.23B | 1.91B | 3.17% |
| Dec 31, 2007 | 60.32B | -2.61B | -4.15% |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.50T |
| SK Biopharmaceuticals | 620.28B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |